
Angel Investor
Lord Moynihan of Chelsea has been an angel investor in the following startups:

Get ready for a groundbreaking revolution in precision medicine for coronary artery disease as PlaqueTec secures £6.4M in funding to advance their innovative biomarker discovery tool, Biocarta®, and ongoing Biopattern trial, aiming to improve understanding of CAD pathobiology and individual variations.
Lord Moynihan of Chelsea is an angel investor based in London, in the UK.
Angel Investors